RE:Proph. the manipulatorfossi_2002 wrote: Comment by
prophetoffactzon Dec 15, 2023 3:57am lscfa wrote: Nov 13, 2023 — HC Wainwright Cuts Aeterna Zentaris' Price Target to $15 From $28, Maintains Buy Rating
With 4.86 million shares according to Stockhouse US$28 would be a US$138 million market cap. That is similar to what Novo Nordisk put into AEZS's growth hormone deficiency test:
...US$145 million plus tiered royalties and an equity investment worth more than US$36
million... Proph... is the biggest manipulator on this board. If Wainwright cuts the price target from 28$ to 15$, the market value is just under 73 million, but he talks about 138 million because he simply uses the old price target - it couldn't be worse!
HC Wainwright is biased as they did the last underwriting with shares at $1.45. Given the 25 for 1 share rollback, it was effectively at $36.25. Shares are at $2.18 for a loss of 96% all in a matter of 3 years.
AEZS is a dog, period.
Until recently, CZO had a very high gross margin de-risked base businses, was generating net profit, had positive cash flow, and adding to its cash to fund it's pipeline with no share dilution over the past 7 years. Hey we just had a "bump" in the road due to the spinoff of Kenvue and re-ordering should normalize soon. Why the panic to merge with a dog like AEZS? A dog is a dog, a NASDAQ listing doesn't hide the fact. After the last financing by AEZS 3 years ago the share price has dropped 96%. And yes, Gagnon rejoined the board on January 1, 2020 to guide them. What a disaster. Why would CZO want any part of this. Vote NO to the merger.